Research ExplorerScientific StaffCarsten Bokemeyer Publications

Prof. Dr. ID: 68114

Carsten Bokemeyer

graph of relations
Affiliations
251 - 300 out of 794Page size: 50

Publications

  1. 2020

  2. Large retroperitoneal lymphadenopathy and increased risk of venous thromboembolism in patients receiving first-line chemotherapy for metastatic germ cell tumors: A study by the global germ cell cancer group (G3)

    Tran, B., Ruiz-Morales, J. M., Gonzalez-Billalabeitia, E., Patrikidou, A., Amir, E., Seidel, C., Bokemeyer, C., Fankhauser, C., Hermanns, T., Rumyantsev, A., Tryakin, A., Brito, M., Fléchon, A., Kwan, E. M., Cheng, T., Castellano, D., Garcia Del Muro, X., Hamid, A. A., Ottaviano, M., Palmieri, G., Kitson, R., Reid, A., Heng, D. Y. C. & Bedard, P. L., 01.2020, In: CANCER MED-US. 9, 1, p. 116-124 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. CARD-Studie – Bedeutung für die Therapie des fortgeschrittenen Prostatakarzinoms

    Merseburger, A. S., Bannowsky, A., Becker, K., Bokemeyer, C., Eichenauer, R., Lehmann, J., Mickisch, G., Steuber, T., von Amsberg, G., von Kügelgen, T. & Wülfing, C., 2020, In: AKTUEL UROL. 2020

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  4. Targeting the Mutational Landscape of Bystander Cells: Drug-Promoted Blood Cancer From High-Prevalence Pre-neoplasias in Patients on BRAF Inhibitors

    Simnica, D., Ittrich, H., Bockemeyer, C., Stein, A. & Binder, M., 2020, In: FRONT ONCOL. 10, p. 540030

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. The Impact of Smoking Cessation and Continuation on Recurrence and Survival in Patients with Head and Neck Cancer: A Systematic Review of the Literature

    von Kroge, P. R., Bokemeyer, F., Ghandili, S., Bokemeyer, C. & Seidel, C., 2020, In: ONCOL RES TREAT. 43, 10, p. 549-558 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. 2019

  7. Fulminant blast crisis with de novo 11q23 rearrangement in a Philadelphia-positive CML patient undergoing treatment with dasatinib

    Janjetovic, S., Asemissen, A. M., Dicker, F., Binder, M., Dierlamm, J., Bokemeyer, C. & Schafhausen, P., 12.2019, In: TUMORI J. 105, 6, p. NP8-NP11

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. Challenges Faced by Prehospital Emergency Physicians Providing Emergency Care to Patients with Advanced Incurable Diseases

    Kamphausen, A., Roese, H., Oechsle, K., Issleib, M., Zöllner, C., Bokemeyer, C. & Ullrich, A., 26.11.2019, In: EMERG MED INT. 2019, p. 3456471

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. Psychological burden in family caregivers of patients with advanced cancer at initiation of specialist inpatient palliative care

    Oechsle, K., Ullrich, A., Marx, G., Benze, G., Heine, J., Dickel, L-M., Zhang, Y., Wowretzko, F., Wendt, K. N., Nauck, F., Bokemeyer, C. & Bergelt, C., 18.11.2019, In: BMC PALLIAT CARE. 18, 1, p. 102

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. The prognostic impact of different tumor marker levels in nonseminomatous germ cell tumor patients with intermediate prognosis: A registry of the International Global Germ Cell Tumor Collaborative Group (G3)

    Seidel, C., Daugaard, G., Tryakin, A., Necchi, A., Cohn-Cedermark, G., Ståhl, O., Hentrich, M., Brito, M., Albany, C., Taza, F., Gerl, A., Oechsle, K., Oing, C. & Bokemeyer, C., 11.2019, In: UROL ONCOL-SEMIN ORI. 37, 11, p. 809.e19-809.e25

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. Successful Targeting of the Warburg Effect in Prostate Cancer by Glucose-Conjugated 1,4-Naphthoquinones

    Dyshlovoy, S. A., Pelageev, D. N., Hauschild, J., Borisova, K. L., Kaune, M., Krisp, C., Venz, S., Sabutskii, Y. E., Khmelevskaya, E. A., Busenbender, T., Denisenko, V. A., Pokhilo, N. D., Atopkina, L. N., Graefen, M., Schlüter, H., Stonik, V. A., Bokemeyer, C., Anufriev, V. P. & von Amsberg, G., 30.10.2019, In: CANCERS. 11, 11, 1690.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. The Actin Binding Protein Plastin-3 Is Involved in the Pathogenesis of Acute Myeloid Leukemia

    Velthaus, A., Cornils, K., Hennigs, J. K., Grüb, S., Stamm, H., Wicklein, D., Bokemeyer, C., Heuser, M., Windhorst, S., Fiedler, W. & Wellbrock, J., 26.10.2019, In: CANCERS. 11, 11

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. Evaluation of Continuous Tumor-Size-Based End Points as Surrogates for Overall Survival in Randomized Clinical Trials in Metastatic Colorectal Cancer

    Burzykowski, T., Coart, E., Saad, E. D., Shi, Q., Sommeijer, D. W., Bokemeyer, C., Díaz-Rubio, E., Douillard, J-Y., Falcone, A., Fuchs, C. S., Goldberg, R. M., Hecht, J. R., Hoff, P. M., Hurwitz, H., Kabbinavar, F. F., Koopman, M., Maughan, T. S., Punt, C. J. A., Saltz, L., Schmoll, H-J., Seymour, M. T., Tebbutt, N. C., Tournigand, C., Van Cutsem, E., de Gramont, A., Zalcberg, J. R., Buyse, M. & Aide et Recherche en Cancerologie Digestive Group, 04.09.2019, In: JAMA NETW OPEN. 2, 9, p. e1911750

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. The P2-receptor-mediated Ca2+ signalosome of the human pulmonary endothelium - implications for pulmonary arterial hypertension

    Hennigs, J. K., Lüneburg, N., Stage, A., Schmitz, M., Körbelin, J., Harbaum, L., Matuszcak, C., Mienert, J., Bokemeyer, C., Böger, R. H., Kiefmann, R. & Klose, H., 09.2019, In: PURINERG SIGNAL. 15, 3, p. 299-311 13 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. High Aldehyde Dehydrogenase Levels Are Detectable in the Serum of Patients with Lung Cancer and May Be Exploited as Screening Biomarkers

    Rossi, A., Voigtländer, M., Klose, H., Schlüter, H., Schön, G., Loges, S., Paolini, M., Bokemeyer, C., Reck, M., Tarro, G. & Binder, M., 22.08.2019, In: J ONCOL. 2019, p. 8970645

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. Apixaban for the Treatment of Chronic Disseminated Intravascular Coagulation: A Report of Two Cases

    Janjetovic, S., Holstein, K., Dicke, C., Bokemeyer, C. & Langer, F., 08.2019, In: HAMOSTASEOLOGIE. 39, 3, p. 294-297 4 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. New Trisulfated Steroids from the Vietnamese Marine Sponge Halichondria vansoesti and Their PSA Expression and Glucose Uptake Inhibitory Activities

    Tabakmakher, K. M., Makarieva, T. N., Denisenko, V. A., Popov, R. S., Dmitrenok, P. S., Dyshlovoy, S. A., Grebnev, B. B., Bokemeyer, C., von Amsberg, G. & Cuong, N. X., 27.07.2019, In: MAR DRUGS. 17, 8

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. Exploring the gender dimension of problems and needs of patients receiving specialist palliative care in a German palliative care unit - the perspectives of patients and healthcare professionals

    Ullrich, A., Grube, K., Hlawatsch, C., Bokemeyer, C. & Oechsle, K., 17.07.2019, In: BMC PALLIAT CARE. 18, 1, p. 59

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. Epigenetic treatment combinations to effectively target cisplatin-resistant germ cell tumors-past, presentand future considerataions

    Oing, C., Skowron, M. A., Bokemeyer, C. & Nettersheim, D., 07.2019, In: ANDROLOGY-US. 2019, 4, p. 487497

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  20. Epigenetic treatment combinations to effectively target cisplatin-resistant germ cell tumors: past, present, and future considerations

    Oing, C., Skowron, M. A., Bokemeyer, C. & Nettersheim, D., 07.2019, In: ANDROLOGY-US. 7, 4, p. 487-497 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  21. Monoklonale Gammopathie unklarer Signifikanz – ein häufiger Nebenbefund: Woran ist zu denken? Was ist zu tun?

    Schieferdecker, A., Binder, M., Weisel, K. & Bokemeyer, C., 07.2019, In: DEUT MED WOCHENSCHR. 144, 14, p. 982-989 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  22. Determination of PD-L1 Expression in Circulating Tumor Cells of NSCLC Patients and Correlation with Response to PD-1/PD-L1 Inhibitors

    Janning, M., Kobus, F., Babayan, A., Wikman, H., Velthaus, J-L., Bergmann, S., Schatz, S., Falk, M., Berger, L-A., Böttcher, L-M., Päsler, S., Gorges, T. M., O'Flaherty, L., Hille, C., Joosse, S. A., Simon, R., Tiemann, M., Bokemeyer, C., Reck, M., Riethdorf, S., Pantel, K. & Loges, S., 17.06.2019, In: CANCERS. 11, 6

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study

    Dieckmann, K-P., Radtke, A., Geczi, L., Matthies, C., Anheuser, P., Eckardt, U., Sommer, J., Zengerling, F., Trenti, E., Pichler, R., Belz, H., Zastrow, S., Winter, A., Melchior, S., Hammel, J., Kranz, J., Bolten, M., Krege, S., Haben, B., Loidl, W., Ruf, C. G., Heinzelbecker, J., Heidenreich, A., Cremers, J. F., Oing, C., Hermanns, T., Fankhauser, C. D., Gillessen, S., Reichegger, H., Cathomas, R., Pichler, M., Hentrich, M., Eredics, K., Lorch, A., Wülfing, C., Peine, S., Wosniok, W., Bokemeyer, C. & Belge, G., 01.06.2019, In: J CLIN ONCOL. 37, 16, p. 1412-1423 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. Outcomes of chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim (Zarzio®) initiated "same-day" ( 72 h): findings from the MONITOR-GCSF study

    Ludwig, H., Gascón, P., Bokemeyer, C., Aapro, M., Boccadoro, M., Denhaerynck, K., Krendyukov, A., MacDonald, K. & Abraham, I., 06.2019, In: SUPPORT CARE CANCER. 27, 6, p. 2301-2312 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  25. Impact of taste and smell training on taste disorders during chemotherapy – TASTE trial

    von Grundherr, J., Koch, B., Grimm, D., Salchow, J., Valentini, L., Hummel, T., Bokemeyer, C., Stein, A. & Mann, J., 16.05.2019, In: CANCER MANAG RES. 11, p. 4493—4504 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  26. Current pharmacotherapy for testicular germ cell cancer

    Alsdorf, W., Seidel, C., Bokemeyer, C. & Oing, C., 05.2019, In: EXPERT OPIN PHARMACO. 20, 7, p. 837-850 14 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  27. Nanobody-targeting of epidermal growth factor receptor (EGFR) ectodomain variants overcomes resistance to therapeutic EGFR antibodies

    Tintelnot, J., Baum, N., Schultheiss, C., Braig, F., Trentmann, M., Finter, J., Fumey, W., Bannas, P., Fehse, B., Riecken, K., Schütze, K., Bokemeyer, C., Rösner, T., Valerius, T., Peipp, M., Koch-Nolte, F. & Binder, M., 04.2019, In: MOL CANCER THER. 18, 4, p. 823-833 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. Positronenemissionstomographie bei Keimzelltumoren des Mannes: Einsatzmöglichkeiten und Grenzen

    Schriefer, P., Hartmann, M., Oechsle, K., Meyer, C. P., Klutmann, S., Fisch, M., Bokemeyer, C. & Oing, C., 04.2019, In: UROLOGE. 58, 4, p. 418-423 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  29. Chemotherapy-induced neutropenia/febrile neutropenia prophylaxis with biosimilar filgrastim in solid tumors versus hematological malignancies: MONITOR-GCSF study

    Ludwig, H., Bokemeyer, C., Aapro, M., Boccadoro, M., Gascón, P., Denhaerynck, K., Krendyukov, A., Abraham, I. & MacDonald, K., 03.2019, In: FUTURE ONCOL. 15, 8, p. 897-907 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. Everolimus in patients with multiply relapsed or cisplatin refractory germ cell tumors: results of a phase II, single-arm, open-label multicenter trial (RADIT) of the German Testicular Cancer Study Group

    Fenner, M., Oing, C., Dieing, A., Gauler, T., Oechsle, K., Lorch, A., Hentrich, M., Kopp, H-G., Bokemeyer, C. & Honecker, F., 03.2019, In: J CANCER RES CLIN. 145, 3, p. 717-723 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. A significant proportion of patients with primary central nervous system lymphoma harbor clonal bone marrow B-cells

    Brandt, A., Matschke, J., Fehrle, W., von Wenserski, L., Bokemeyer, C., Illerhaus, G. & Binder, M., 02.2019, In: LEUKEMIA LYMPHOMA. 60, 2, p. 334-340 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  32. SWITCH II: Phase III randomized, sequential, open-label study to evaluate the efficacy and safety of sorafenib-pazopanib versus pazopanib-sorafenib in the treatment of advanced or metastatic renal cell carcinoma (AUO AN 33/11)

    Retz, M., Bedke, J., Bögemann, M., Grimm, M-O., Zimmermann, U., Müller, L., Leiber, C., Teber, D., Wirth, M., Bolenz, C., van Alphen, R., De Santis, M., Beeker, A., Lehmann, J., Indorf, M., Frank, M., Bokemeyer, C. & Gschwend, J. E., 01.2019, In: EUR J CANCER. 107, p. 37-45 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  33. Cancer Cells Expressing Oncogenic Rat Sarcoma Show Drug-Addiction Toward Epidermal Growth Factor Receptor Antibodies Mediated by Sustained MAPK Signaling

    Tintelnot, J., Metz, S., Trentmann, M., Oberle, A., von Wenserski, L., Schultheiß, C., Braig, F., Kriegs, M., Fehse, B., Riecken, K., Bokemeyer, C., Stein, A. & Binder, M., 2019, In: FRONT ONCOL. 9, p. 1559

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  34. Fatal Myelotoxicity Following Palliative Chemotherapy With Cisplatin and Gemcitabine in a Patient With Stage IV Cholangiocarcinoma Linked to Post Mortem Diagnosis of Fanconi Anemia

    Engel, N. W., Schliffke, S., Schüller, U., Frenzel, C., Bokemeyer, C., Kubisch, C. & Lessel, D., 2019, In: FRONT ONCOL. 9, p. 420

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  35. Lokal-ablative Radiotherapie des oligometastasierten Prostatakarzinoms mit Überlebensvorteil

    Oing, C., Petersen, C. & Bokemeyer, C., 2019, In: ONKOLOGE. 25, 9, p. 827-828 2 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  36. Roadmap 2019 für die Erforschung von Krebs- und Bluterkrankungen in Deutschlan

    Hallek, M., Bokemeyer, C., Lüftner, D. & Weissinger, F., 2019, (Gesundheitspolitische Schriftenreihe der DGHO; vol. 15)

    Research output: Book/anthology › Collected edition/anthology › Transfer

  37. Targeting the TIGIT-PVR immune checkpoint axis as novel therapeutic option in breast cancer

    Stamm, H., Oliveira-Ferrer, L., Grossjohann, E-M., Muschhammer, J., Thaden, V., Brauneck, F., Kischel, R., Müller, V., Bokemeyer, C., Fiedler, W. & Wellbrock, J., 2019, In: ONCOIMMUNOLOGY. 8, 12, p. e1674605

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  38. 2018

  39. 5-Azacitidine Exerts Prolonged Pro-Apoptotic Effects and Overcomes Cisplatin-Resistance in Non-Seminomatous Germ Cell Tumor Cells

    Oing, C., Verem, I., Mansour, W. Y., Bokemeyer, C., Dyshlovoy, S. & Honecker, F., 21.12.2018, In: INT J MOL SCI. 20, 1, p. 21

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  40. Identification of a High-Level MET Amplification in CTCs and cfTNA of an ALK-Positive NSCLC Patient Developing Evasive Resistance to Crizotinib

    Berger, L-A., Janning, M., Velthaus, J-L., Ben-Batalla, I., Schatz, S., Falk, M., Iglauer, P., Simon, R., Cao, R., Forcato, C., Manaresi, N., Bramlett, K., Buson, G., Hanssen, A., Tiemann, M., Sauter, G., Bokemeyer, C., Riethdorf, S., Reck, M., Pantel, K., Wikman, H. & Loges, S., 12.2018, In: J THORAC ONCOL. 13, 12, p. e243-e246

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  41. Palliative treatment of germ cell cancer

    Oing, C., Giannatempo, P., Honecker, F., Oechsle, K., Bokemeyer, C. & Beyer, J., 12.2018, In: CANCER TREAT REV. 71, p. 102-107 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  42. Clinicopathological differences and survival outcomes with first-line therapy in patients with left-sided colon cancer and rectal cancer: Pooled analysis of 2879 patients from AGITG (MAX), COIN, FOCUS2, OPUS, CRYSTAL and COIN-B trials in the ARCAD database

    Salem, M. E., Yin, J., Weinberg, B. A., Renfro, L. A., Pederson, L. D., Maughan, T. S., Adams, R. A., Van Cutsem, E., Falcone, A., Tebbutt, N. C., Seymour, M. T., Díaz-Rubio, E., Aranda, E., Bokemeyer, C., Heinemann, V., Wasan, H., de Gramont, A., Grothey, A., Shi, Q., Sargent, D. J. & Marshall, J. L., 11.2018, In: EUR J CANCER. 103, p. 205-213 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  43. Psychoonkologische Versorgung in Deutschland: Bundesweite Bestandsaufnahme und Analyse: Wissenschaftliches Gutachten im Auftrag des Bundesministeriums für Gesundheit

    Schulz, H., Bleich, C., Dabs, M., Frerichs, W., Sautier, L., Bokemeyer, C., Koch-Gromus, U. & Härter, M., 31.10.2018, 360 p.

    Research output: Book/anthology › Monographs › Research › peer-review

  44. Multi-omic based molecular profiling of advanced cancer identifies treatable targets and improves survival in individual patients

    Samsen, A., von der Heyde, S., Bokemeyer, C., David, K. A., Flath, B., Graap, M., Grebenstein, B., Heflik, L., Hollburg, W., Layer, P., von Leitner, E., Overkamp, F., Saeger, W., Schneider, S., von Seydewitz, C-U., Stang, A., Stein, A., Zornig, C. & Juhl, H., 05.10.2018, In: ONCOTARGET. 9, 78, p. 34794-34809 16 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  45. Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines

    Aapro, M., Beguin, Y., Bokemeyer, C., Dicato, M., Gascón, P., Glaspy, J., Hofmann, A., Link, H., Littlewood, T., Ludwig, H., Österborg, A., Pronzato, P., Santini, V., Schrijvers, D., Stauder, R., Jordan, K., Herrstedt, J. & ESMO Guidelines Committee, 01.10.2018, In: ANN ONCOL. 29, Suppl 4, p. iv96-iv110

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  46. Biological basis and early clinical results of immunotherapy for cisplatin-resistant germ cell cancer

    Oing, C. & Bokemeyer, C., 09.2018, In: CURR OPIN UROL. 28, 5, p. 479-484 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  47. Immune checkpoints PVR and PVRL2 are prognostic markers in AML and their blockade represents a new therapeutic option

    Stamm, H., Klingler, F., Grossjohann, E-M., Muschhammer, J., Vettorazzi, E., Heuser, M., Mock, U., Thol, F., Vohwinkel, G., Latuske, E., Bokemeyer, C., Kischel, R., Dos Santos, C., Stienen, S., Friedrich, M., Lutteropp, M., Nagorsen, D., Wellbrock, J. & Fiedler, W., 09.2018, In: ONCOGENE. 37, 39, p. 5269-5280 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  48. The impact of bleeding disorders on the socioeconomic status of adult patients. Results of a comparative single centre cohort study

    Holstein, K., von Mackensen, S., Bokemeyer, C. & Langer, F., 10.08.2018, In: HAMOSTASEOLOGIE. 38, 3, p. 150-157 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  49. ESMO Consensus Conference on testicular germ cell cancer: past, present, and future considerations: diagnosis, treatment and follow-up

    Honecker, F., Aparicio, J., Berney, D., Beyer, J., Bokemeyer, C., Cathomas, R., Clarke, N., Cohn-Cedermark, G., Daugaard, G., Dieckmann, K-P., Fizazi, K., Fosså, S., Germa-Lluch, J. R., Giannatempo, P., Gietema, J. A., Gillessen, S., Haugnes, H. S., Heidenreich, A., Hemminki, K., Huddart, R., Jewett, M. A. S., Joly, F., Lauritsen, J., Lorch, A., Necchi, A., Nicolai, N., Oing, C., Oldenburg, J., Ondruš, D., Papachristofilou, A., Powles, T., Sohaib, A., Ståhl, O., Tandstad, T., Toner, G. & Horwich, A., 01.08.2018, In: ANN ONCOL. 29, 8, p. 1658-1686 29 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  50. Blockade of myeloid-derived suppressor cell expansion with all-trans retinoic acid increases the efficacy of anti-angiogenic therapy

    Bauer, R., Udonta, F., Wroblewski, M., Ben-Batalla, I., Santos, I. M., Taverna, F., Kuhlencord, M., Gensch, V., Päsler, S., Vinckier, S., Brandner, J. M., Pantel, K., Bokemeyer, C., Vogl, T., Roth, J., Carmeliet, P. & Loges, S., 15.06.2018, In: CANCER RES. 78, 12, p. 3220-3232 13 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  51. BCL2-overexpressing prostate cancer cells rely on PARP1-dependent end-joining and are sensitive to combined PARP inhibitor and radiation therapy

    Oing, C., Tennstedt, P., Simon, R., Volquardsen, J., Borgmann, K., Bokemeyer, C., Petersen, C., Dikomey, E., Rothkamm, K. & Mansour, W. Y., 01.06.2018, In: CANCER LETT. 423, p. 60-70 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  52. Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram Project

    Sjoquist, K. M., Renfro, L. A., Simes, R. J., Tebbutt, N. C., Clarke, S., Seymour, M. T., Adams, R., Maughan, T. S., Saltz, L., Goldberg, R. M., Schmoll, H-J., Van Cutsem, E., Douillard, J-Y., Hoff, P. M., Hecht, J. R., Tournigand, C., Punt, C. J. A., Koopman, M., Hurwitz, H., Heinemann, V., Zalcberg, J. R. & Fondation Aide et Recherche en Cancerologie Digestive Group (ARCAD), 01.06.2018, In: JNCI-J NATL CANCER I. 110, 6, p. 638-648 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  53. BET-inhibition by JQ1 promotes proliferation and self-renewal capacity of hematopoietic stem cells

    Wroblewski, M., Scheller-Wendorff, M., Udonta, F., Bauer, R., Schlichting, J., Zhao, L., Ben Batalla, I., Gensch, V., Päsler, S., Wu, L., Wanior, M., Taipaleenmäki, H., Bolamperti, S., Najafova, Z., Pantel, K., Bokemeyer, C., Qi, J., Hesse, E., Knapp, S., Johnsen, S. & Loges, S., 06.2018, In: HAEMATOLOGICA. 103, 6, p. 939-948 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 12 3 4 5 6 7 8 9 ...16 Next